Freezing a Tumor to -50 Degrees C Kills Cancer Cells Through Two Distinct Mechanisms
When liquid nitrogen hits tumor tissue at -196 degrees C, ice crystals form inside cells and rupture their membranes. Then, as the tissue thaws, the blood vessels feeding the frozen zone clot and collapse, cutting off oxygen to any cells that survived the initial freeze. Repeating this freeze-thaw cycle two to three times per session maximizes the kill zone.
The lethal zone extends concentrically from the cryoprobe or spray nozzle. The center achieves the coldest temperatures and highest kill rates. Peripheral tissue may sustain sublethal injury — damaged but not destroyed — which can lead to incomplete ablation if the treatment margin is inadequate.
Thermocouple monitoring allows the surgeon to verify that lethal temperatures reach the deep margin of the tumor. Without temperature monitoring, the surgeon must estimate depth and completeness from the visible ice ball, which is less reliable.
Tumor Types and Clinical Applications
Oral Tumors
Cryosurgery has its strongest evidence base in canine oral tumor management. Murphy et al. (2011) reported outcomes for cryosurgery of oral tumors in dogs, demonstrating effective local control for small (less than 2 cm) epulides, acanthomatous ameloblastomas, and selected squamous cell carcinomas. The advantage over surgical mandibulectomy or maxillectomy is functional preservation — cryosurgery destroys the tumor while maintaining jaw structure, which preserves eating function and cosmetic appearance.
For acanthomatous ameloblastoma (previously called acanthomatous epulis), cryosurgery achieves local control rates comparable to marginal excision, with reported recurrence rates of 10-20%. Given that the alternative is often partial mandibulectomy, cryosurgery offers a significant quality-of-life advantage for tumors accessible to adequate freezing.
Oral melanoma, however, responds poorly to cryosurgery alone due to its aggressive biological behavior and high metastatic rate. While cryosurgery can achieve local palliation, it does not address the systemic disease that ultimately determines survival. Combining cryosurgery with immunotherapy (melanoma vaccine) is sometimes used to leverage a potential abscopal effect — tumor antigen release from cryodestruction may enhance the immune response.
Skin Tumors
Krahwinkel (1980) and Withrow (1984) established the early evidence for cryosurgery of cutaneous tumors in dogs. Suitable candidates include:
- Small benign tumors (papillomas, sebaceous adenomas, small histiocytomas) where excision would require general anesthesia disproportionate to the procedure
- Perianal adenomas — cryosurgery is particularly effective for these testosterone-dependent tumors and is often combined with castration
- Eyelid tumors where surgical excision risks lid margin distortion — cryosurgery preserves lid architecture while destroying tumor tissue
- Small mast cell tumors (Grade I, less than 1 cm) in locations where wide surgical margins are anatomically impossible
Larger or higher-grade skin tumors are generally better served by surgical excision with histopathologic margin assessment, which cryosurgery cannot provide. This is the fundamental limitation: cryosurgery destroys the tissue in place, so margin evaluation is impossible. There is no specimen to submit for pathology.
Nasal Planum Tumors
Squamous cell carcinoma of the nasal planum — more common in cats but occurring in dogs, particularly those with depigmented noses — responds well to cryosurgery for small, superficial lesions. Multiple treatment sessions may be required, with local control rates of 70-85% reported for tumors under 2 cm.
Advantages Over Conventional Surgery
Cryosurgery offers several practical advantages in appropriate cases:
- Reduced anesthesia requirements. Many superficial procedures can be performed under sedation and local anesthesia rather than general anesthesia, reducing risk for senior dogs or those with cardiac or respiratory compromise.
- Tissue preservation. In the oral cavity, around the eyes, and on the nasal planum, cryosurgery destroys tumor while maintaining surrounding anatomical structures.
- Hemostasis. Frozen tissue does not bleed during the procedure, which is advantageous for highly vascularized tumors or patients with coagulopathies.
- Equipment cost. Compared to electrosurgery, laser surgery, or radiation therapy, cryosurgery equipment is relatively inexpensive.
- Repeatability. Sessions can be repeated if recurrence develops, without the cumulative tissue damage associated with repeated radiation.
Limitations and Risks
No Histopathologic Margins
The inability to assess surgical margins is the most significant limitation. With conventional excision, the pathologist can evaluate whether the tumor was completely removed with clean margins. Cryosurgery provides no such confirmation — the clinician must rely on visual assessment and temperature monitoring to judge treatment adequacy.
Healing by Second Intention
Cryosurgery creates a zone of necrotic tissue that sloughs over 2-4 weeks, leaving a wound that heals by second intention (granulation and epithelialization). The healing period is longer than primary surgical closure, and the resulting scar may be cosmetically inferior. Wound care during the sloughing phase requires owner compliance and monitoring for secondary infection.
Depth Uncertainty
For tumors with significant depth (greater than 5-8 mm below the surface), achieving lethal temperatures at the deep margin becomes unreliable. Temperature gradients within the ice ball mean that peripheral tissue may survive, leading to deep recurrence that is harder to detect and treat than surface recurrence.
Not Suitable for Aggressive Cancers
High-grade malignancies with significant metastatic potential — including osteosarcoma, high-grade mast cell tumors, and oral melanoma — are not appropriate candidates for cryosurgery as primary therapy. Local control does not address the systemic disease, and incomplete local treatment may delay more effective interventions.
Postoperative Course
The typical sequence after cryosurgery involves:
- Immediate edema and erythema (hours 0-24) at the treatment site
- Blister formation (days 1-3) as damaged tissue separates
- Eschar formation (days 3-7) as necrotic tissue desiccates
- Sloughing (days 7-21) of the eschar, revealing granulation tissue
- Epithelialization (weeks 3-8) and scar maturation
Pain is generally moderate and well-controlled with standard analgesics. Oral cryosurgery patients typically resume eating within 24-48 hours, though softened food is recommended during the healing phase.
When to Consider Cryosurgery
Cryosurgery occupies a specific niche in canine oncology. It does not replace conventional surgery in most cases, but it offers a valuable option when anatomical location, patient factors, or tumor biology favor tissue-preserving ablation over excision.
The best candidates are small, superficial, well-defined tumors in anatomically sensitive locations in dogs where anesthesia risk is a concern. For any tumor where complete staging and margin assessment are priorities, conventional surgical excision remains the standard of care.
Frequently Asked Questions
What types of tumors can be treated with cryosurgery in dogs?
Cryosurgery is most effective for superficial and accessible tumors including small skin tumors, oral masses, eyelid tumors, and perianal tumors. It is particularly useful when conventional surgical excision would be technically difficult or disfiguring. It is not appropriate for large, deep, or metastatic tumors where complete tissue destruction cannot be assured.
Is cryosurgery painful for dogs?
Dogs typically experience mild discomfort during the procedure, which can be performed under local anesthesia or light sedation for most superficial lesions. Post-procedure, the treated area may be sore and swollen for several days as the frozen tissue undergoes necrosis and sloughing. Pain management during recovery is straightforward with standard analgesics.
How does cryosurgery compare to conventional surgery for tumor removal?
Cryosurgery offers advantages including shorter procedure times, lower anesthesia requirements, and the ability to treat tumors in locations where surgical excision is difficult. However, conventional surgery provides a tissue sample for histopathology (confirming complete removal and tumor type), while cryosurgery destroys tissue in situ without providing a sample for analysis.
What is the success rate of cryosurgery for dog tumors?
Success rates depend on tumor type and size. For small, well-defined superficial tumors, local control rates of 80-95% are reported. Larger tumors and those with irregular margins have lower complete response rates. Cryosurgery may require repeat treatments if the tumor is not fully destroyed in a single session.
Bottom Line
Cryosurgery is a practical option for small, superficial, well-defined tumors in anatomically sensitive locations — particularly oral epulides, perianal adenomas, and eyelid tumors — where surgical excision would be disproportionately invasive. Its key limitation is the inability to assess margins histopathologically, meaning treatment completeness relies on the surgeon’s judgment rather than pathology confirmation. Cryosurgery is not appropriate for aggressive or deeply invasive cancers where staging and margin assessment are priorities.
References
- Krahwinkel DJ. Cryosurgical treatment of skin diseases (Veterinary Clinics of North America: Small Animal Practice, 1980).
- Withrow SJ. Cryosurgery of canine and feline tumors (Journal of the American Animal Hospital Association, 1984).
- Murphy S et al. Cryosurgery in the management of oral tumours in dogs (Journal of Small Animal Practice, 2011).
- Goldschmidt MH, Hendrick MJ. Tumors of the skin and soft tissues (Tumors in Domestic Animals, 4th ed., 2002).